EVALUATION OF KALLISTATIN AS A BIOMARKER IN CHRONIC HEPATITIS C PATIENTS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 9
Abstract
Early outcome prediction after hepatitis C viral infections has a great interest. This study aims to evaluate kallistatin in the prediction of liver fibrosis in chronic hepatitis C Egyptian patients. This study included 62 patients with chronic HCV infection (30 patients suffering from early liver fibrosis, 16 with advanced liver fibrosis, 16 with HCC) and 14 healthy subjects. Serum liver function tests were determined by colorimetric methods, HBsAg, HCVAb, AFP, CRP and kallistatin were investigated by ELISA, HCV-RNA and the expression of SERPINA4 gene were determined by qRT-PCR assay, abdominal ultrasound and ultrasonic-guided liver biopsy were done to determine the stage of fibrosis. Serum kallistatin level was significantly lower in patients with chronic liver disease (CLD) than healthy subjects at the gene expression and protein levels (P=0.003 & 0.001, respectively). Also, there was a significant difference in kallistatin concentration in early and advanced fibrosis, (p=0.044). Serum kallistatin had greater sensitivity and NPV values than did AST/ALT ratio (AAR) and AST/platelet ratio index (APRI) in patients with CLD compared with healthy subjects with sensitivity 95.1%, specificity 50%, PPV 89.2%, and NPV 70%. Moreover, Kallistatin could significantly distinguish patients at early stage of liver fibrosis from healthy subjects with sensitivity 96.7% and specificity 50%. Compared with single detection, combined measurement of the AAR, APRI and kallistatin markers showed 90% sensitivity and 78.6% specificity, 90% PPV and 78.6% NPV. These data support that kallistatin may be an efficient biomarker in early detection of fibrosis. Also, it suggested that combination of kallistatin with AAR and APRI could improve the sensitivity and specificity for the diagnosis of CLD and this can be used as a practical method for clinical diagnosis for the early stage of liver fibrosis.
Authors and Affiliations
Halla M. Ragab & Wafaa Abd Elaziz
Keywords
Related Articles
- EP ID EP618642
- DOI -
- Views 159
- Downloads 0
SYNTHESIS, IDENTIFICATION AND ANTIBACTERIAL EVALUATION OF SOME 1,3,4- OXADIAZOLES DERIVATIVE ON 1,8-NAPHTHYRIDINE RING
Several 1,8-naphthyridine derivative were prepared using Vilsmeier-Haack synthization. 2-chloro-3-formyl-1,8-naphthyridine was synthesized by reacting N-(pyridin-2-yl) acetamide with POCl3 in dimethylformamide. 1,8-napht...
A REVIEW OF RICINUS COMMUNIS LINN.
Ricinus communis Linn. is a widely described plant since ancient time in Vedas, Puranas, Samhitas and Nighantus. It is generally used in diseases in neuro-muscular disorders like generalized pain, inflammation, hemiplegi...
UNDERSTANDING OF NIDRA AS A COMPONENT OF TRAYOUPASTHAMBHA
The Trayopastambha are considered as the subsidiary pillars, which supports and activates the body of the human beings throughout the life span by providing with different qualities like Bala, Varna, Upchaya etc. The Tra...
SYNTHESIS, CHARACTERISATION, ANTIMICROBIAL EVALUATION OF 2-HYDROXY PHENYL THIAZOLIDINE-4-ONE DERIVATIVE
A new series of N-(2-(2-hydroxyphenyl)-4-oxothiazolidin-3-yl) isonicotinamide derivatives were synthesized by the reaction of schiff base (Isoniazid and 2 hydroxy benzaldehyde) with mercaptoacetic acid respectively. The...
EVALUATION OF ANTIDEPRESSANT, ANTIDIARRHEAL AND ANTIULCERANT ACTIVITIES OF HYDNOCARPUS KURZII LEAF EXTRACTS
Hydnocarpus kurzii commonly known as Chaulmugra, found in hill tract areas, are commonly used for the treatment of leprosy and skin diseases for their high medicinal value. The methanolic leaf extract of H. kurzii was su...